scholarly article | Q13442814 |
P356 | DOI | 10.2903/J.EFSA.2009.231R |
P50 | author | European Food Safety Authority | Q516521 |
P2860 | cites work | Kappa-casein and beta-caseins in human milk micelles: structural studies | Q24309042 |
Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen | Q24613961 | ||
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study | Q28204926 | ||
Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime | Q28212769 | ||
A genome-wide search for human type 1 diabetes susceptibility genes | Q28247197 | ||
Insulin in human milk and the prevention of type 1 diabetes | Q28249932 | ||
Anti-BSA antibodies do not cross-react with the 69-kDa islet cell autoantigen ICA69 | Q28278671 | ||
A population based strategy to prevent insulin-dependent diabetes using nicotinamide | Q28299381 | ||
Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen | Q28306502 | ||
Mice lacking MHC class II molecules | Q28588991 | ||
Preparation and amino acid sequence of human kappa-casein | Q28609884 | ||
Human alpha s1-casein: purification and characterization | Q28609887 | ||
Role of oxidative modifications in atherosclerosis | Q29617974 | ||
Peptic digestion of beta-casein. Time course and fate of possible bioactive peptides. | Q30319768 | ||
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport | Q30321148 | ||
IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent). | Q30585261 | ||
Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends | Q31473026 | ||
Designing of an orally active complement C3a agonist peptide with anti-analgesic and anti-amnesic activity | Q31942482 | ||
Identification of peptides in milk as a result of proteolysis at different levels of somatic cell counts using LC MALDI MS/MS detection | Q33316882 | ||
Absence of urinary opioid peptides in children with autism | Q33323518 | ||
Antihypertensive peptides derived from bovine casein and whey proteins | Q37053769 | ||
Update on coeliac disease and type 1 diabetes mellitus in childhood | Q37110078 | ||
The antihypertensive effect of peptides: a novel alternative to drugs? | Q37126940 | ||
Circulating oxidized low-density lipoproteins are associated with overweight, obesity, and low serum carotenoids in older community-dwelling women | Q37129934 | ||
Opioids and the control of respiration | Q37154550 | ||
Bioactive peptides and proteins from foods: indication for health effects | Q37174449 | ||
Oxidation of LDL and its clinical implication | Q37215823 | ||
Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. | Q37247193 | ||
Leaking gut in type 1 diabetes | Q37362144 | ||
Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study | Q37422165 | ||
Incidence and prevalence of type 1 (insulin-dependent) diabetes mellitus in Icelandic children 1970-1989 | Q38513708 | ||
Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes | Q33474458 | ||
Development of neuropeptide drugs that cross the blood-brain barrier | Q33569277 | ||
Beta-casein in cow's milk: a major antigenic determinant for type 1 diabetes? | Q33727433 | ||
Environmental factors in the pathogenesis of type 1 diabetes mellitus. | Q33752334 | ||
Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties | Q33757977 | ||
HLA-DQ6-mediated protection in IDDM. | Q33863194 | ||
Milk and diabetes | Q33887959 | ||
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training | Q33938878 | ||
Bioactive milk peptides: a prospectus | Q33956865 | ||
Identification of two related pentapeptides from the brain with potent opiate agonist activity | Q34134593 | ||
Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes | Q34159440 | ||
Novel opioid peptides derived from hemoglobin: hemorphins | Q34189176 | ||
Opiate Receptor: Demonstration in Nervous Tissue | Q34216480 | ||
Specificity of a cell-envelope-located proteinase (PIII-type) from Lactococcus lactis subsp. cremoris AM1 in its action on bovine beta-casein | Q34246724 | ||
Milk drinking, ischaemic heart disease and ischaemic stroke I. Evidence from the Caerphilly cohort. | Q34317269 | ||
Type 1 diabetes: new perspectives on disease pathogenesis and treatment | Q34321603 | ||
Opioid receptors | Q34326054 | ||
A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? | Q34384858 | ||
Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY) | Q34393984 | ||
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection | Q34411408 | ||
IDDM and early infant feeding. Sardinian case-control study | Q34418116 | ||
International Union of Pharmacology. XLVI. G protein-coupled receptor list. | Q34421152 | ||
Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood | Q34477784 | ||
Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein | Q34505167 | ||
A naturally occurring opioid peptide from cow's milk, beta-casomorphine-7, is a direct histamine releaser in man | Q34539685 | ||
Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory | Q34579739 | ||
Autism: a review of the state of the science for pediatric primary health care clinicians | Q34579776 | ||
Polymorphism of bovine beta-casein and its potential effect on human health | Q34581530 | ||
Rubiscolin, a delta selective opioid peptide derived from plant Rubisco | Q34647389 | ||
Rubiscolin-6, a delta opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating sigma1 and dopamine D1 receptors | Q34654899 | ||
Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing | Q34680444 | ||
Principles of study design in environmental epidemiology | Q34845134 | ||
Dairy cattle production in Europe | Q35033353 | ||
Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? | Q35074298 | ||
Is "somatic" angiotensin I-converting enzyme a mechanosensor? | Q35103316 | ||
Food-derived bioactive peptides--opportunities for designing future foods | Q35137708 | ||
Opioid receptor ligands derived from food proteins | Q35137714 | ||
Transcytosis: crossing cellular barriers | Q35169907 | ||
Pathophysiologic implications of angiotensin I-converting enzyme as a mechanosensor: diabetes | Q35181766 | ||
Milk consumption, stroke, and heart attack risk: evidence from the Caerphilly cohort of older men. | Q35559388 | ||
Bioactive peptides and proteins | Q35593485 | ||
Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. | Q35759554 | ||
Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population | Q35820963 | ||
Micronutrients and the risk of type 1 diabetes: vitamin D, vitamin E, and nicotinamide. | Q35924732 | ||
Multifunctional peptides encrypted in milk proteins | Q35998643 | ||
Is type 1 diabetes a disease of the gut immune system triggered by cow's milk insulin? | Q36246708 | ||
Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice. | Q36301274 | ||
Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. | Q36363509 | ||
Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins | Q36377040 | ||
Effects of dietary factors on oxidation of low-density lipoprotein particles. | Q36413899 | ||
Transport systems for opioid peptides in mammalian tissues | Q36440370 | ||
Endomorphins as agents for the treatment of chronic inflammatory disease | Q36489167 | ||
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. | Q36627730 | ||
Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations | Q36666056 | ||
Opioids, sleep architecture and sleep-disordered breathing | Q36671584 | ||
Milk Proteins in the Etiology of Insulin-Dependent Diabetes Mellitus (IDDM) | Q36689792 | ||
Food-derived peptides with biological activity: from research to food applications | Q36733200 | ||
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction | Q36741881 | ||
The endomorphin system and its evolving neurophysiological role | Q36747911 | ||
A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group | Q36756210 | ||
Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production | Q36789704 | ||
Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives | Q36795351 | ||
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins | Q36905127 | ||
Designer milk | Q36953801 | ||
Pathophysiology and management of opioid-induced pruritus. | Q36993379 | ||
Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths | Q36996571 | ||
Structural investigation of endomorphins by experimental and theoretical methods: hunting for the bioactive conformation | Q37032429 | ||
Prevalence and ten-year (1970-1979) incidence of insulin-dependent diabetes mellitus in children and adolescents in Finland. | Q50588379 | ||
Childhood onset diabetes--time trends and climatological factors. | Q50596495 | ||
Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. | Q50610289 | ||
Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. | Q50639626 | ||
Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children. The Finnish Childhood Type I Diabetes Registry Group. | Q50648758 | ||
Effect of beta-casein, kappa-casein and beta-lactoglobulin genotypes on concentration of milk protein variants. | Q50655106 | ||
Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group. | Q50667674 | ||
Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. | Q50787251 | ||
Cow's milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood Diabetes in Finland Study Group. | Q50866523 | ||
Significance of cow's milk protein antibodies as risk factor for childhood IDDM: interactions with dietary cow's milk intake and HLA-DQB1 genotype. Childhood Diabetes in Finland Study Group. | Q50903257 | ||
IDDM and milk consumption. A case-control study in São Paulo, Brazil. | Q50942473 | ||
Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. | Q51007959 | ||
Nitrate in community water supplies and risk of childhood type 1 diabetes in Sardinia, Italy. | Q51244598 | ||
Caseinomacropeptide specifically stimulates exocrine pancreatic secretion in the anesthetized rat. | Q51373245 | ||
Stress-induced breakdown of intestinal barrier function in the rat: reversal by wood creosote. | Q52019511 | ||
Behavioral and pharmacological studies on gluten exorphin A5, a newly isolated bioactive food protein fragment, in mice. | Q52022333 | ||
A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. | Q52950394 | ||
Comparison of milk protein allele frequencies in Nordic cattle breeds. | Q53752674 | ||
Lack of immunity to bovine serum albumin in insulin-dependent diabetes mellitus. | Q53816973 | ||
RELATION BETWEEN BREAST-FEEDING AND INCIDENCE RATES OF INSULIN-DEPENDENT DIABETES MELLITUS | Q54032170 | ||
Effect of diet on incidence of diabetes in nonobese diabetic mice. | Q54097263 | ||
Anti-bovine serum albumin antibodies: genetic heterogeneity and clinical relevance in adult-onset IDDM. | Q54181632 | ||
Demonstration of a beta-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. | Q54441121 | ||
Casocidin-I: a casein-alpha s2 derived peptide exhibits antibacterial activity. | Q54603583 | ||
Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. | Q55034326 | ||
The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry | Q55670898 | ||
Elimination Diets in Autism Spectrum Disorders | Q55897107 | ||
Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins | Q56454905 | ||
Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility | Q56524301 | ||
Islet cell autoantigen 69 antibodies in IDDM | Q56601172 | ||
Opioid peptides and dipeptidyl peptidase in autism | Q56785723 | ||
Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group | Q57397708 | ||
Breast-feeding seems to play a marginal role in the prevention of insulin-dependent diabetes mellitus | Q57449617 | ||
Identification of Casoxin C, An Ileum-contracting Peptide Derived From Bovine κ -casein, as an Agonist for C3a Receptors | Q57550757 | ||
Does casomorphin have a functional role? | Q57952003 | ||
Estimation of Milk Protein Gene Frequencies in Crossbred Cattle by Maximum Likelihood | Q58189906 | ||
Infant Feeding in Finnish Children <7 yr of Age With Newly Diagnosed IDDM | Q58417592 | ||
Inherited Casein Variants in Cow's Milk | Q58985066 | ||
Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature | Q38569312 | ||
Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus | Q38730863 | ||
Genetic variants of casein in Indian and African Zebu cattle | Q38897092 | ||
Regional differences in the incidence of insulin-dependent diabetes mellitus among children in Finland from 1987 to 1991. Childhood Diabetes in Finland (DiMe) Study Group | Q39456313 | ||
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections | Q39474763 | ||
Casein, a prohormone with an immunomodulating role for the newborn? | Q39633587 | ||
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. | Q39774757 | ||
Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients | Q39784479 | ||
The extracellular PI-type proteinase of Lactococcus lactis hydrolyzes beta-casein into more than one hundred different oligopeptides | Q39837234 | ||
Transport of micro-opioid receptor agonists and antagonist peptides across Caco-2 monolayer. | Q40000119 | ||
HLA and Disease 1982 - A Survey | Q40146426 | ||
beta-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a mu-opioid pathway | Q40339679 | ||
MHC ligands and peptide motifs: first listing | Q40612811 | ||
Early environmental events as a cause of IDDM. Evidence and implications | Q40662621 | ||
Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes | Q40678165 | ||
Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides | Q40971518 | ||
Susceptibility to type I diabetes: HLA-DQ and DR revisited | Q41078428 | ||
Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells | Q41080361 | ||
High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. | Q41097998 | ||
Breast feeding and the development of type 1 diabetes mellitus | Q41117472 | ||
Relationship between cows' milk consumption and incidence of IDDM in childhood | Q41149377 | ||
Panning for gold: genome-wide scanning for linkage in type 1 diabetes | Q41170315 | ||
Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome | Q41196484 | ||
Breast feeding and insulin-dependent diabetes mellitus in children | Q41393355 | ||
Reduced risk of IDDM among breast-fed children. The Colorado IDDM Registry | Q41403990 | ||
Antibacterial activities of peptides from the water-soluble extracts of Italian cheese varieties | Q41458071 | ||
Protein and nonprotein nitrogen components in human milk, bovine milk, and infant formula: quantitative and qualitative aspects in infant nutrition | Q41460624 | ||
Casein and peptide degradation in lactic acid bacteria | Q41503031 | ||
Biochemical properties of regulatory peptides derived from mil proteins | Q41525024 | ||
Diabetes produced in mice by smoked/cured mutton | Q41533460 | ||
Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase | Q41562794 | ||
Low density lipoprotein oxidation and its pathobiological significance | Q41566828 | ||
Diet and coronary disease: a survey of mortality rates and food consumption statistics of 24 countries | Q41638781 | ||
Bioavailability and transport of peptides and peptide drugs into the brain | Q41657628 | ||
Viruses and other perinatal exposures as initiating events for beta-cell destruction | Q41695561 | ||
Absence of HeLa cell contamination in 169 cell lines derived from human tumors | Q41761715 | ||
Identification of a novel Na+- and Cl--coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat | Q41847542 | ||
Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones | Q42011739 | ||
Absorption of intact morphiceptin by diisopropylfluorophosphate-treated rabbit ileum | Q42023668 | ||
Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties | Q42252165 | ||
Effect of β-Casomorphins and Analogs on Insulin Release in Dogs* | Q42454486 | ||
Peptides identified during Emmental cheese ripening: origin and proteolytic systems involved | Q43029360 | ||
Interaction of enkephalins with oxyradicals | Q43588644 | ||
Interaction of enkephalin derivatives with reactive oxygen species. | Q43600690 | ||
Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group | Q43607374 | ||
Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum | Q43668211 | ||
Relation of time of introduction of cow milk protein to an infant and risk of type-1 diabetes mellitus | Q43915385 | ||
Effects of peptides derived from dietary proteins on mucus secretion in rat jejunum | Q44103987 | ||
Albumin binding as a general strategy for improving the pharmacokinetics of proteins | Q44209151 | ||
Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy | Q44261024 | ||
Opioid peptides derived from wheat gluten: their isolation and characterization | Q44330711 | ||
Novel opioid peptides derived from human beta-casein: human beta-casomorphins | Q44330856 | ||
How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance? | Q44332145 | ||
Soymorphins, novel mu opioid peptides derived from soy beta-conglycinin beta-subunit, have anxiolytic activities | Q44336502 | ||
Opioid allergic reactions #175. | Q44339342 | ||
Gluten exorphin C. A novel opioid peptide derived from wheat gluten | Q44340580 | ||
Tissue distribution of opioid receptor gene expression in the rat. | Q44341274 | ||
Opioid activities of human beta-casomorphins | Q44346646 | ||
Release of opioid peptides, gluten exorphins by the action of pancreatic elastase | Q44346704 | ||
Hydrolysis of casein accelerates gastrointestinal transit via reduction of opioid receptor agonists released from casein in rats. | Q44347426 | ||
Effect of two synthetic alpha-gliadin peptides on lymphocytes in celiac disease: identification of a novel class of opioid receptors | Q44347861 | ||
Gluten exorphin B5 stimulates prolactin secretion through opioid receptors located outside the blood-brain barrier | Q44348013 | ||
Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study | Q44352056 | ||
Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation | Q44352080 | ||
Opioid activities of β-casomorphins | Q44352850 | ||
New susceptibility haplotype for type 1 diabetes. DIME Study Group | Q44429914 | ||
A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes | Q44514412 | ||
Blood antigen, serum protein, and milk protein gene frequencies and genetic interrelationships in Holstein cattle | Q44561685 | ||
Beta-casein variants and atherosclerosis-claims are premature | Q44574918 | ||
A casein variant in cow's milk is atherogenic | Q44574921 | ||
Infant diet and type 1 diabetes in China | Q44619965 | ||
Effects of beta-casomorphin-5 on passive avoidance response in mice | Q44674563 | ||
Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in Caco-2 cell monolayers | Q44755783 | ||
T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies | Q44792670 | ||
Antibodies Against Bovine Albumin and Other Diabetes Markers in French Children | Q45152409 | ||
Early infant diet and risk of IDDM in blacks and whites. A matched case-control study | Q45160193 | ||
HLA-DQB1 Alleles and Absence of Asp 57 as Susceptibility Factors of IDDM in Finland | Q45420704 | ||
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland | Q46088274 | ||
HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Q46138865 | ||
VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides | Q46305248 | ||
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. | Q46364386 | ||
Re-evaluation of the whey protein/casein ratio of human milk | Q46364734 | ||
The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. | Q46587728 | ||
Neurite outgrowth-stimulating activities of beta-casomorphins in Neuro-2a mouse neuroblastoma cells | Q46603808 | ||
A comparison of the effects of A1 and A2 beta-casein protein variants on blood cholesterol concentrations in New Zealand adults | Q46812432 | ||
Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin | Q46832616 | ||
Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice | Q46855570 | ||
Derivatives of beta-casomorphins with high analgesic potency | Q46890953 | ||
Effect of dietary supplementation with beta-casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease | Q46915418 | ||
Influence of human B-casomorphin-7 on specific binding of 3H-spiperone to the 5-HT2-receptors of rat brain frontal cortex. | Q46939467 | ||
Cellular immune responses to beta casein: elevated in but not specific for individuals with Type I diabetes mellitus | Q47854149 | ||
Penetration of dynorphin 1-13 across the blood-brain barrier | Q47930872 | ||
Immunology in diabetes: an update | Q48030355 | ||
Reactions between beta-casomorphins-7 and 5-HT2-serotonin receptors | Q48507335 | ||
Casomorphins reduce separation distress in chicks | Q48648991 | ||
Antinociceptive potencies of β-casomorphin analogs as compared to their affinities towards μ and δ opiate receptor sites in brain and periphery | Q48906923 | ||
Antimutagenic effects of milk fermented by Lactobacillus helveticus L89 and a protease-deficient derivative | Q50133275 | ||
Autism and Schizophrenia: Intestinal Disorders | Q50313358 | ||
Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. | Q50510554 | ||
Increasing incidence of diabetes mellitus in Norwegian children 0-14 years of age 1973-1982. | Q50558618 | ||
P433 | issue | 2 | |
P304 | page(s) | 231r | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | EFSA Journal | Q56298557 |
P1476 | title | Review of the potential health impact of β-casomorphins and related peptides | |
P478 | volume | 7 |
Q88201551 | Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot study | cites work | P2860 |
Search more.